← Open Payments lookup

MICHAEL CANTWELL: Open Payments

NPI 1750381059 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$710 in 29 payments from 12 companies in 2025. Trend: 2023 $515 · 2024 $477 · 2025 $710

Food & beverage: $572Education: $139
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$194
Axsome Therapeutics, Inc.4$190
Vanda Pharmaceuticals Inc.3$70
Neurocrine BioSciences, Inc.2$48
Alkermes, Inc.3$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Biogen, Inc.1$29
E.R. Squibb & Sons, L.L.C.1$27
Takeda Pharmaceuticals U.S.A., Inc.1$21
Janssen Pharmaceuticals, Inc1$18

Products named: Auvelity, FANAPT, INGREZZA, AUSTEDO XR, CAPLYTA, UZEDY, ARISTADA, ZURZUVAE.

Industry payments across IN — which companies pay providers there.